We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
A new campaign to raise awareness of the fire risk and the precautions that need to be taken by users of skin creams has been launched today
Ground-breaking innovation to support medical technologies
The MHRA is aware of certificates being issued by certification bodies headed “certificates of compliance” or “Attestation of Compliance”.
Today’s publication of the Independent Medicines and Medical Devices Safety Review is of profound importance for the MHRA, since the safety of the public is our first priority.
Warning that thermal cameras and other such “temperature screening” products, some of which make direct claims to screen for COVID-19, are not a reliable way to detect if people have the virus.
Recent media reports have suggested that chloroquine can protect patients from coronavirus or treat COVID-19, the illness caused by a coronavirus.
The MHRA has approved the recruitment of further participants for a clinical trial by the University of Oxford
The Medicines and Healthcare products Regulatory Agency (MHRA) has instructed UK clinical trialists using hydroxychloroquine to treat or prevent coronavirus (COVID-19) to suspend recruitment of further participants.
A convicted fugitive faces the confiscation of £1.4 million in prime assets by the Crown, following a hearing at Southwark Crown Court today.
Anyone supplying these types of tests should temporarily stop this service.
MHRA has today given the first positive scientific opinion under the Early Access to Medicines Scheme (EAMS) for use of Gilead’s remdesivir.
Allergy patients who carry Emerade 500 microgram adrenaline auto-injector pens should contact their prescriber and seek replacement pens of a different brand.
Ministers are seeking to appoint a Chair of the Medicines and Healthcare products Regulatory Agency (MHRA).
Lynda Scammell, Senior Enforcement Advisor at the Medicines and Healthcare products Regulatory Agency (MHRA) today warned the public about medicines and other medical products being sold online claiming to treat or prevent C…
A new biological reagent is now available to labs around the UK and the world that will help them to set up and develop accurate diagnostic tests for coronavirus (COVID-19).
A new online reporting site, dedicated to reporting any suspected side effects from medicines, future vaccines and incidents involving medical equipment relating to COVID-19 treatment, has today been launched.
We are prioritising and giving tailored scientific advice for potential treatments for coronavirus (COVID-19).
First published during the 2019 to 2022 Johnson Conservative government
Expert Working Group concludes there is currently insufficient evidence to establish a link between use of ibuprofen and susceptibility to contracting COVID-19 or the worsening of its symptoms.
Allergy patients who carry Emerade 300 microgram adrenaline auto-injector pens should contact their prescriber and seek replacement pens of a different brand. This applies to Emerade 300 microgram pens that are still in-date…
A man and a woman who sold breast cancer and erectile dysfunction medicines illegally online appeared at Birmingham Crown Court.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).